Introduction
Aarjoint is a prescription medication that combines three active ingredients: Diacerein, Glucosamine Sulfate Potassium Chloride, and Methyl Sulfonyl Methane. It is available in tablet form and is used for the treatment of certain joint disorders.
Uses
Aarjoint is commonly prescribed for the management of osteoarthritis, a degenerative joint disease that causes pain, inflammation, and stiffness in the joints. It helps to relieve symptoms such as joint pain and improves joint mobility.
Dosage and Administration
The dosage of Aarjoint may vary depending on the severity of the condition and individual patient response. Follow the instructions provided by your healthcare professional. Typically, the recommended dosage is one tablet taken orally, twice a day with meals. Swallow the tablet whole with a glass of water, without crushing or chewing it.
Mechanism of Action
Aarjoint contains three active ingredients that work together to provide therapeutic effects. Diacerein helps to reduce inflammation in the joints by inhibiting certain enzymes involved in the inflammatory process. Glucosamine Sulfate Potassium Chloride is a natural component of cartilage and helps to maintain its structure and function. Methyl Sulfonyl Methane provides sulfur, which is important for the formation of connective tissues in the joints.
Side Effects
Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as allergic reactions, skin rashes, or difficulty breathing, seek immediate medical attention.
Drug Interactions
inform your healthcare professional about all the medications you are taking, including prescription and over-the-counter drugs, as well as any herbal supplements. Aarjoint may interact with certain medications, such as anticoagulants (blood thinners) or antiplatelet drugs, leading to an increased risk of bleeding. Discuss potential drug interactions with your healthcare provider before starting Aarjoint.
Precautions
Before taking Aarjoint, inform your healthcare professional about any existing medical conditions, including kidney or liver problems, as well as any allergies. This medication should be used with caution in patients with a history of gastrointestinal disorders. Aarjoint is not recommended for use in pregnant or breastfeeding women. It is also advisable to avoid alcohol consumption while taking this medication, as it may increase the risk of gastrointestinal side effects.
Storage
Patient Tips
- Take Aarjoint as prescribed by your healthcare professional, and do not exceed the recommended dosage.
- It may take some time for the medication to show its full effect. Be patient and continue taking it regularly.
- If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- If you have any concerns or questions about your treatment with Aarjoint, do not hesitate to consult your healthcare professional for guidance. They can provide personalized advice based on your specific medical condition and needs.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Vitamins and minerals – Others (NHS UK) [Accessed 8 Jun. 2024] (online) Available at:
- Boots Rehydration Treatment (Health Professionals SmPC) Available at:
- Diacerein (International database) (Drugs.com) [Accessed 1 Jun. 2024] (online) Available at:
- fp glucosamine capsule () [Accessed 8 Jun. 2024] (online) Available at:
- Glucosamine (MedlinePlus) [Accessed 14 Jun. 2024] (online) Available at:
- Spencer CM, Wilde MI. Diacerein. Drugs. 1997 Jan;53(1):98-106; discussion 107-8. doi: 10.2165/00003495-199753010-00007. [Accessed 28 Jun. 2024] Available at:
Reviews
There are no reviews yet.